戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ld standard for the measurement of effective renal plasma flow.
2 ld standard for the measurement of effective renal plasma flow.
3 ld standard for the measurement of effective renal plasma flow.
4 lomerular hyperfiltration and an increase in renal plasma flow.
5                                              Renal plasma flow (4.83+/-0.65 versus 2.37+/-0.62 ml/min
6 anied by declines in plasma NO and effective renal plasma flow and an increase in renal vascular resi
7                                              Renal plasma flow and plasma aldosterone were measured b
8                                              Renal plasma flow and plasma renin activity were measure
9 h chronic heart failure, serelaxin increased renal plasma flow and reduced the increase in filtration
10                       Glomerular filtration, renal plasma flow, and clearance of the stable metabolit
11 ession, greater body mass index, lower basal renal plasma flow, and higher diastolic blood pressure t
12 s associated with lower GFR, lower effective renal plasma flow, and higher filtration fraction, even
13          Functional renal reserve, change in renal plasma flow, and percentage change in nitrate and
14 rate; GFR) and paraaminohippurate (effective renal plasma flow) clearances were measured in individua
15  tracer with a capacity to measure effective renal plasma flow comparable to that of the clinical gol
16 8 +/- 6% greater GFR, and a 61 +/- 7% higher renal plasma flow, compared with lean dogs.
17 still substantial and sustained increases in renal plasma flow, cortical blood flow (20 +/- 4% increa
18                                              Renal plasma flow decreased similarly with Ang II infusi
19 partmental analysis for estimating effective renal plasma flow (ERPF in units of milliliters per minu
20 nstrumented rats increases GFR and effective renal plasma flow (ERPF) and decreases effective renal v
21 r recombinant human RLX 2 (rhRLX), effective renal plasma flow (ERPF) and glomerular filtration rate
22 ronic inhibition of NO synthase on effective renal plasma flow (ERPF) and glomerular filtration rate
23 n 3 d) that includes estimation of effective renal plasma flow (ERPF) from a single plasma sample in
24 dy, we retrospectively review 1626 effective renal plasma flow (ERPF) measurements in 197 patients wi
25                                    Effective renal plasma flow (ERPF) response to angiotensin II (Ang
26 n cortical blood flow (34 +/- 12% increase), renal plasma flow, GFR, and sodium excretion; however, t
27 iltration rate (I-iothalamate) and effective renal plasma flow (I-hippuran) measured 4 months before
28           Fenoldopam significantly increased renal plasma flow in a dose-dependent manner compared wi
29 n was used to independently assess effective renal plasma flow in each subject.
30 ficant changes in mean arterial pressure and renal plasma flow in either C or D rats but reduced glom
31 renin inhibition led to a larger increase in renal plasma flow in healthy human volunteers studied on
32 perfiltrating and showed the largest rise in renal plasma flow in response to irbesartan, whereas ren
33                                              Renal plasma flow increased by 29% with serelaxin and 14
34                                    Effective renal plasma flow increased in both groups after surgery
35                                              Renal plasma flow increased modestly between baseline an
36  on GFR (measured by iothalamate clearance), renal plasma flow (measured by para-amino hippurate clea
37  glomerular filtration rate (GFR), effective renal plasma flow, natriuresis, and diuresis.
38 creased plasma renin activity (P < 0.01) and renal plasma flow (P < 0.01); the latter effect plateaue
39                                              Renal plasma flow (para-aminohippurate clearance) and gl
40             In the second part of the study, renal plasma flow (para-aminohippurate clearance) and gl
41                 PUA, GFR (inulin), effective renal plasma flow (para-aminohippurate), BP, and hemodyn
42  difference between serelaxin and placebo on renal plasma flow (para-aminohippuric acid clearance) an
43 hanges from baseline mean arterial pressure, renal plasma flow, plasma renin activity, aldosterone, u
44                                              Renal plasma flow, prevalence of acute kidney injury, in
45 ced the glomerular filtration rate (GFR) and renal plasma flow rate in diabetic rats, despite variabl
46                  Arterial pressure, GFR, and renal plasma flow remained constant, but CsA restored th
47 -aminohippurate were used to measure GFR and renal plasma flow, respectively.
48 asma flow in response to irbesartan, whereas renal plasma flow rose less and GFR fell in patients wit
49 mide on glomerular filtration rate (GFR) and renal plasma flow (RPF) in heart failure patients are co
50  intrarenal renin activity, we have examined renal plasma flow (RPF) responses in a standardized prot
51                In all three groups, baseline renal plasma flow (RPF) was positively correlated with t
52                                      GFR and renal plasma flow (RPF) were measured as the clearance o
53 easured glomerular filtration rate (GFR) and renal plasma flow (RPF), and analysed renal structural i
54            Glomerular filtration rate (GFR), renal plasma flow (RPF), and filtration fraction (FF) (a
55 ong the three centers, but systolic BP, GFR, renal plasma flow (RPF), and filtration fraction were lo
56                               Bilateral GFR, renal plasma flow (RPF), and para-aminohippurate (PAH) e
57                               Bilateral GFR, renal plasma flow (RPF), and para-aminohippurate extract
58 s showed parallel increases in single-kidney renal plasma flow (RPF), renocortical volume, and glomer
59              The glomerular filtration rate, renal plasma flow, urinary albumin excretion, and blood
60  There were no differences in GFR, effective renal plasma flow, urine output, or sodium excretion for
61 y [GC]/mass spectrometry [MS] analysis), and renal plasma flow was determined with paraaminohippurate
62                      Irrespective of gender, renal plasma flow was increased by 47% compared with bas
63                                              Renal plasma flow was measured by para-aminohippurate cl
64 sured with infusion of [6-(2)H2]glucose, and renal plasma flow was measured by para-aminohippurate cl
65                                              Renal plasma flow was measured by using paraaminohippura
66                    In male MRL-lpr/lpr mice, renal plasma flow was significantly reduced in the 5lo-/
67                   In contrast, corresponding renal plasma flow was the same in the two groups, such t
68                                              Renal plasma flow was unchanged at 293 +/- 124 ml/min/1.
69               Glomerular filtration rate and renal plasma flow were measured with iothalamate and par

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。